• 1
    Cooperberg MR, Broering JM, Litwin MS et al. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry. J Urol 2004; 171: 13931401
  • 2
    Hoang AN, Volkin D, Yerram NK et al. Image guidance in the focal treatment of prostate cancer. Curr Opin Urol 2012; 22: 328335
  • 3
    Lindner U, Trachtenberg J, Lawrentschuk N. Focal therapy in prostate cancer: modalities, findings and future considerations. Nat Rev Urol 2010; 7: 562571
  • 4
    Hildebrandt B, Wust P, Ahlers O et al. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol 2002; 43: 3356
  • 5
    Ahmed HU, Freeman A, Kirkham A et al. Focal therapy for localized prostate cancer: a phase I/II trial. J Urol 2011; 185: 12461254
  • 6
    Lindner U, Lawrentschuk N, Weersink RA et al. Focal laser ablation for prostate cancer followed by radical prostatectomy: validation of focal therapy and imaging accuracy. Eur Urol 2010; 57: 11111114
  • 7
    Lukka H, Waldron T, Chin J et al. High-intensity focused ultrasound for prostate cancer: a systematic review. Clin Oncol (R Coll Radiol) 2011; 23: 117127
  • 8
    Ahmed HU, Hindley RG, Dickinson L et al. Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study. Lancet Oncol 2012; 13: 622632
  • 9
    Chopra R, Colquhoun A, Burtnyk M et al. MR imaging-controlled transurethral ultrasound therapy for conformal treatment of prostate tissue: initial feasibility in humans. Radiology 2012; 265: 303313
  • 10
    Siddiqui K, Chopra R, Vedula S et al. MRI-guided transurethral ultrasound therapy of the prostate gland using real-time thermal mapping: initial studies. Urology 2010; 76: 15061511
  • 11
    Meshorer A, Prionas SD, Fajardo LF, Meyer JL, Hahn GM, Martinez AA. The effects of hyperthermia on normal mesenchymal tissues. Application of a histologic grading system. Arch Pathol Lab Med 1983; 107: 328334
  • 12
    Ishihara Y, Calderon A, Watanabe H, Okamoto K, Suzuki Y, Kuroda K. A precise and fast temperature mapping using water proton chemical shift. Magn Reson Med 1995; 34: 814823
  • 13
    Chen J, Daniel BL, Diederich CJ et al. Monitoring prostate thermal therapy with diffusion-weighted MRI. Magn Reson Med 2008; 59: 13651372
  • 14
    Jacobs MA, Herskovits EH, Kim HS. Uterine fibroids: diffusion-weighted MR imaging for monitoring therapy with focused ultrasound surgery–preliminary study. Radiology 2005; 236: 196203
  • 15
    Chopra R, Tang K, Burtnyk M et al. Analysis of the spatial and temporal accuracy of heating in the prostate gland using transurethral ultrasound therapy and active MR temperature feedback. Phys Med Biol 2009; 54: 26152633
  • 16
    Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 1984; 10: 787800
  • 17
    Trivedi H, Turkbey B, Rastinehad AR et al. Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer. Urology 2012; 79: 233239
  • 18
    Shah V, Pohida T, Turkbey B et al. A method for correlating in vivo prostate magnetic resonance imaging and histopathology using individualized magnetic resonance-based molds. Rev Sci Instrum 2009; 80: 104301
  • 19
    Turkbey B, Mani H, Shah V et al. Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. J Urol 2011; 186: 18181824
  • 20
    Makin CA, Bobrow LG, Bodmer WF. Monoclonal antibody to cytokeratin for use in routine histopathology. J Clin Pathol 1984; 37: 975983
  • 21
    Van Leenders GJ, Beerlage HP, Ruijter ET, de la Rosette JJ, van de Kaa CA. Histopathological changes associated with high intensity focused ultrasound (HIFU) treatment for localised adenocarcinoma of the prostate. J Clin Pathol 2000; 53: 391394
  • 22
    Jonmarker S, Valdman A, Lindberg A, Hellstrom M, Egevad L. Tissue shrinkage after fixation with formalin injection of prostatectomy specimens. Virchows Arch 2006; 449: 297301
  • 23
    Foster RS, Bihrle R, Sanghvi N et al. Production of prostatic lesions in canines using transrectally administered high-intensity focused ultrasound. Eur Urol 1993; 23: 330336
  • 24
    Gelet A, Chapelon JY, Margonari J et al. Prostatic tissue destruction by high-intensity focused ultrasound: experimentation on canine prostate. J Endourol 1993; 7: 249253
  • 25
    Ahmed HU. The index lesion and the origin of prostate cancer. N Engl J Med 2009; 361: 17041706
  • 26
    Sciarra A, Barentsz J, Bjartell A et al. Advances in magnetic resonance imaging: how they are changing the management of prostate cancer. Eur Urol 2011; 59: 962977
  • 27
    Turkbey B, Pinto PA, Mani H et al. Prostate cancer: value of multiparametric MR imaging at 3 T for detection – histopathologic correlation. Radiology 2010; 255: 8999
  • 28
    Diederich CJ, Stafford RJ, Nau WH, Burdette EC, Price RE, Hazle JD. Transurethral ultrasound applicators with directional heating patterns for prostate thermal therapy: in vivo evaluation using magnetic resonance thermometry. Med Phys 2004; 31: 405413